SLCO1B1, SLCO2B1, and SLCO1B3 Polymorphisms and Susceptibility to Bladder Cancer Risk

REFERENCES

• Letašiová S, Medve'ová A, Šovčíková A, Dušinská M, Volkovová K, Mosoiu C, Bartonová A. Bladder cancer, a review of the environmental risk factors. Environ Health 2012;11(Suppl 1):S11.
   PubMed Web of Science ®Google Scholar
• Kakehi Y, Hirao Y, Kim WJ, Ozono S, Masumori N, Miyanaga N, Nasu Y, Yokomizo A. Bladder Cancer Working Group Report. Jpn J Clin Oncol 2010;40(Suppl 1):i57–i64.
   PubMed Web of Science ®Google Scholar
• Kiriluk KJ, Prasad SM, Patel AR, Steinberg GD, Smith ND. Bladder cancer risk from occupational and environmental exposures. Urol Oncol 2012;30(2):199–211.
   PubMed Web of Science ®Google Scholar
• Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, Reeder JE. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol 2008;8:7.
   PubMedGoogle Scholar
• Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007;99(7):558–568.
   PubMed Web of Science ®Google Scholar
• Gu J, Wu X. Genetic susceptibility to bladder cancer risk and outcome. Per Med 2011;8(3):365–374.
   PubMed Web of Science ®Google Scholar
• Niemi M, Pasanen MK, Neuvonen PJ. Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 2011;63(1):157–181.
   PubMed Web of Science ®Google Scholar
• Yang M, Xie W, Mostaghel E, Nakabayashi M, Werner L, Sun T, Pomerantz M, Freedman M, Ross R, Regan M, Sharifi N, Figg WD, Balk S, Brown M, Taplin ME, Oh WK, Lee GS, Kantoff PW. SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2011;29(18):2565–2573.
   PubMed Web of Science ®Google Scholar
• Fujimoto N, Kubo T, Inatomi H, Bui HT, Shiota M, Sho T, Matsumoto T. Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation. Prostate Cancer Prostatic Dis 2013;16(4):336–340.
   PubMed Web of Science ®Google Scholar
• Pressler H, Sissung TM, Venzon D, Price DK, Figg WD. Expression of OATP family members in hormone-related cancers: potential markers of progression. PLoS One 2011;6(5):e20372.
   PubMed Web of Science ®Google Scholar
• Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 2011;32(2):182–189.
   PubMed Web of Science ®Google Scholar
• Inatomi H, Katoh T, Kawamoto T, Matsumoto T. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. Int J Urol 1999;6(9):446–454.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumours, Vol. 6. New York: Wiley, 1998.
   Google Scholar
• Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V. Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicol Lett 2010;193(2):131–137.
   PubMed Web of Science ®Google Scholar
• Christoforidou EP, Riza E, Kales SN, Hadjistavrou K, Stoltidi M, Kastania AN, Linos A. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence. J Environ Sci Health A Tox Hazard Subst Environ Eng 2013;48(14):1764–1775.
   PubMed Web of Science ®Google Scholar
• Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21(6):392–401.
   PubMed Web of Science ®Google Scholar
• Knight A, Askling J, Granath F, Sparen P, Ekbom A. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 2004;63(10):1307–1311.
   PubMed Web of Science ®Google Scholar
• Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, Hamdi K, Cherif M, Ben Slama MR, Sfaxi M, Othman FB, Chebil M, Elgaaied AB, Ouerhani S. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer 2011;11:101.
   PubMed Web of Science ®Google Scholar
• Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. DNA repair gene XRCCI polymorphisms and bladder cancer risk. BMC Genetics 2007;4:8–13.
   Google Scholar
• Buxhofer-Ausch V, Secky L, Wlcek K, Svoboda M, Kounnis V, Briasoulis E, Tzakos AG, Jaeger W, Thalhammer T. Tumor-Specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. J Drug Deliv 2013;2013:863539.
   PubMedGoogle Scholar
• Hu M, Mak VW, Yin OQ, Chu TT, Tomlinson B. Effects of grapefruit juice and SLCO1B1 388A> G polymorphism on the pharmacokinetics of pitavastatin. Drug Metab Pharmacokinet 2013;28(2):104–108.
   PubMed Web of Science ®Google Scholar
• Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M. Guideline on non-muscle-invasive bladder cancer. Eur Assoc Urol 2013;64(4):639–653.
   PubMed Web of Science ®Google Scholar
• Palmeira C, Oliveira PA, Lameiras C, Amaro T, Silva VM, Lopes C, Santos L. Biological similarities between murine chemical-induced and natural human bladder carcinogenesis. Oncol Lett 2010;1(2):373–377.
   PubMed Web of Science ®Google Scholar
• Ogawa K, St John M, Luiza de Oliveira M, Arnold L, Shirai T, Sun TT, Cohen SM. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice. Toxicol Pathol 1999;27(6):645–651.
   PubMed Web of Science ®Google Scholar
• Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002;506–507:65–77.
   PubMed Web of Science ®Google Scholar
• Michalski C, Cui Y, Nies AT, Nuessler AK, Neuhaus P, Zanger UM, Klein K, Eichelbaum M, Keppler D, Konig J. A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem 2002;277(45):43058–43063.
   PubMed Web of Science ®Google Scholar